baber/WOPTO huggingface dataset:
Patent CA-2714757-A1 (CA)
Title: Low viscosity liquid polymeric delivery system
Inventor: DUNN RICHARD L
IPC: A61K33/243
Filed: 2009-01-13
Abstract: Low viscosity biodegradable polymer solutions of a liquid biodegradable polymer and biocompatible solvent and methods using the compositions to form a biodegradable liquid polymer implant are provided. Liquid biodegradable polymers are dissolved in non-toxic biocompatible organic solvents to form low viscosity solutions that can be easily injected into the body with standard syringes and small gauge needles. Once the liquid polymer solution is placed within the body, the solvent dissipates or diffuses away from the polymer leaving a more viscous liquid polymer implant suitable, for example, for delivery of a biologically active agent or for use as a medical or surgical device. Because the polymer composition is a low viscosity liquid, it can be injected into muscle or subcutaneous tissue without damage to the surrounding tissue and without the noticeable bump observed with solid implant.
Patent CA-2718872-A1 (CA)
Inventor: GREGOR VLAD EDWARD
IPC: C07D487/04
Filed: 2009-03-18
Abstract: Provided are compounds of the formula (I): or a stereoisomer, tautomer, salt, hydrate or prodrug thereof that modulate tyrosine kinase activity, compositions comprising the compounds and methods of their use.
Patent CA-2719107-A1 (CA)
Inventor: SILVERBROOK KIA
IPC: G06F3/033
Filed: 2009-06-04
Abstract: An electronic pen having a retractable nib for interacting with a surface. The pen comprises a slidably movable cartridge having a nib for contacting the surface, a retraction mechanism for retracting the cartridge, an actuator coupled to the retraction mechanism, a force sensor providing a reaction to an axial force transmitted from the cartridge, and a processor configured for generating force data indicative of a force detected by the force sensor. The retraction mechanism comprises a barrel for receiving the cartridge, which is adapted for seating the cartridge in either an extended position or a retracted position, whereby the axial force from the cartridge is transmitted to the barrel in the extended position. A biasing mechanism biases the cartridge towards the extended or retracted positions.
Patent CA-2720480-A1 (CA)
Inventor: BROSCHEIT JENS
IPC: A61K31/715
Filed: 2009-04-01
Abstract: The invention relates to a pharmaceutical preparation for applying a pharmaceutical agent. According to the invention, the preparation contains: a) a pharmaceutical agent which has an aromatic group or an aromatic part and the molecule of which has a maximum diameter of < 2 nm; b) a permethylated cyclodextrin having a degree of substitution of 3 methyl groups per glucopyranose unit. The permethylated cyclodextrin and the pharmaceutical agent form a complex.
Patent CA-2723446-A1 (CA)
Inventor: REMOUE TYLER
IPC: A01B73/04
Filed: 2010-12-03
Abstract: A stack-fold implement having a central bulk fill hopper assembly is provided.  The bulk fill hopper assembly is mounted to the center frame section of the stack-fold implement and does not affect the narrowness of the stack-fold implement when it's in a stacked, transport position.  The hopper assembly includes a pair of bulk fill hoppers or tanks supported by cradle that is in turn supported by a pair of wheels. The cradle is removably coupled to the center frame section by a plurality of rigid frame members.
Patent CA-2724200-A1 (CA)
Inventor: PURANEN TERHI
IPC: C12N9/24
Filed: 2009-05-22
Abstract: The invention relates to the use of one or more pectinolytic enzyme(s) for the treatment of fruit or vegetable mash as well as a process for enzymatic treatment of fruit or vegetable mash comprising the step of adding one or more pectinolytic enzyme(s), wherein at least one pectinolytic enzyme is obtainable from Trichoderma reesei, as well as to a process for the preparation of a fruit or vegetable juice comprising the process for enzymatic treatment of fruit or vegetable mash. Moreover, the invention discloses recombinant DNA molecules encoding a polypeptide having endo-polygalacturonase activity, a polypeptide having exo-polygalacturonase activity, a polypeptide having exo-rhamnogalacturonase activity and a polypeptide having xylogalacturonase activity.
Patent CA-2725012-A1 (CA)
Inventor: DAY BRIAN J
IPC: A61K31/409
Filed: 2009-05-26
Abstract: The present invention relates a catalytic antioxidant metalloporphyrin for use as a therapeutic or prophylactic agent against the toxic effects associated with exposure to an alkylating agent. Such an alkylating agent includes a sulfur mustard, a nitrogen mustard, chlorine gas, 2-chloroethyl ethyl sulfide, or phosgene. Specifically disclosed is a compound of the formula below or a pharmaceutically acceptable salt thereof:
Patent CA-2725136-A1 (CA)
Inventor: WANG XIAOLIN
IPC: G06F15/78
Filed: 2009-01-26
Abstract: The invention resides in a flexible data pipeline structure for accommodating software computational instructions for varying application programs and having a programmable embedded processor with internal pipeline stages the order and length of which varies as fast as every clock cycle based on the instruction sequence in an application program preloaded into the processor, and wherein the processor includes a data switch matrix selectively and flexibly interconnecting pluralities of mathematical execution units and memory units in response to said instructions, and wherein the execution units are configurable to perform operations at different precisions of multi-bit arithmetic and logic operations and in a multi-level hierarchical architecture structure.
Patent CA-2726268-A1 (CA)
Inventor: BUFFET PIERRE ANTOINE
IPC: G01N33/80
Filed: 2009-05-28
Abstract: The invention relates to a method for screening compounds for their ability to increase rigidity of red blood cells (RBCs) infected by a protozoan parasite of the genus Plasmodium and in particular by Plasmodium falciparum. The present inven-tion also relates to a method for filtering RBCs that enables retention, in a filtering unit, of RBCs having an abnormal and in par-ticular a decreased deformability, as a surrogate for spleen filtering function. Said method enables in particular isolating and/or de-tecting Plasmodium- infected RBCs or spherocytes associated with acquired or hereditary spherocytosis from a sample of blood from a patient, or analysing in vitro spleen function of a patient. The invention also relates to the application of said methods, for the selection of compounds which selectively interact with iRBCs or selectively interact with ring-iRBCs and are suitable to in-crease their rigidity or to application of the method for filtering RBCs, for isolating and/or detecting RBCs with abnormal and es-pecially reduced deformability. This new filtration method is also amenable to automation and allows the clearance or concentra-tion of stiff RBCs, with wide experimental and medical applications in inherited or acquired RBC disorders (including malaria).
Patent CA-2728827-A1 (CA)
Inventor: NGUYEN HUY X
IPC: D06B3/06
Filed: 2009-06-19
Abstract: A method of making colored multifilament ultrahigh molecular weight polyolefin yarn, including feeding at least one substantially untwisted multifilament ultrahigh molecular weight polyolefin yarn, coating the substantially untwisted multifil-ament yarn with a coating composition comprising colorant in a thermoplastic resin carrier, with the coating composition being adhered to the filaments of the multifilament yarn, and heating the multifilament yarn while stretching the yarn without fusing of the filaments of the multifilament yarn. The resultant yarn is a colored multifilament yarn having improved color-fastness. The thermoplastic resin has a lower melting point than the filaments of the multifilament yarn. Preferably, a plurality of the substantial-ly untwisted multifilament ultrahigh molecular weight polyolefin yarns are processed together. Articles formed from the colored multifilament yarns may be prepared and subjected to a heating step to provide a colored surface coating of the thermoplastic resin over the article.
Patent CA-2729831-A1 (CA)
Title: Functional sheet
Inventor: FREDERIX FILIP
IPC: B32B27/00
Filed: 2009-07-09
Abstract: The invention is directed to a functional sheet, to a method for preparing said sheet, to a packaging material and to the use of said packaging material. The functional sheet of the invention comprises a porous polymeric carrier having a porosity of at least 60 %, preferably at least 80 %, more preferably at least 90 %, wherein said polymeric carrier comprises one or more functional compounds, which functional compound provides said sheet with at least one function selected from sensing, scavenging and releasing and wherein the polymeric carrier comprises one or more polyolefins and the average pore size of the polymeric carrier is at least 0.11 µm.
Patent CA-2733360-A1 (CA)
Inventor: MACNAUGHTON BOYD
IPC: G02B30/25
Filed: 2011-03-01
Abstract: A viewing system for viewing video displays having the appearance of a three dimensional image.
Patent CA-2735568-A1 (CA)
Title: Self-actuating closure mechanisms for closable articles
Inventor: HAJICHRISTOU LOUIS
IPC: B65D50/06
Filed: 2009-07-23
Abstract: A self-activating closure mechanism is described, wherein containers (2) and closures (3) have closure elements (9,10), which, upon being brought into proximity to each other, are drawn together and urged into alignment to engage locking members (4,5) by magnets or other mutually attractive or repulsive elements, thereby providing a self-closing assembly.
Patent CA-2736560-A1 (CA)
Inventor: KIKUCHI KAZUMI
IPC: C07D265/30
Filed: 2009-09-10
Abstract: Disclosed is an acid addition salt of (+)-2-[(inden-7-yloxy)methyl]morpholine (compound A), which is intended to be used as a pharmaceutical agent or an active ingredient for a pharmaceutical agent, and has high storage stability, particularly high stability toward humidity and light. Also disclosed is a novel crystal of the acid addition salt. An acid addition salt of compound A with an acid selected from benzenesulfonic acid and hydrobromic acid is a compound which can be isolated in the form of a crystal, takes a solid form at room temperature, exhibits hygroscopicity at such a level that there is no problem for use as a pharmaceutical agent or an active ingredient for a pharmaceutical agent, has stability toward humidity and light, and is therefore extremely useful as a pharmaceutical agent or an active ingredient for a pharmaceutical agent.
Patent CA-2739476-A1 (CA)
Inventor: PEDERSEN MIKKEL WANDAHL
IPC: G01N33/50
Filed: 2009-10-06
Abstract: A method for identifying and selecting chemical entities that contributes to a functional effect in the development of new combinatorial drugs. The combinations of two or more chemical compounds show a synergistic effect. The compounds can be e.g. antibodies, antibiotics, anti-cancer agents, anti-AIDS agents, anti-growth factors, antiviral agents, soluble receptors, cytokines, RNAi's, vaccines and mixtures thereof. The method comprises a) providing n samples each comprising a chemical entity, b) mixing 2 or more of the n samples in all possible combinations, c) subjecting this mixture to a functional assay in order to identify entities contributing to the functional effect. The steps a-c are repeated on the chemical entities from step c which contribute to the functional effect.
Patent CA-2739951-A1 (CA)
Title: Circuit for controlling light emitting diodes and light-and/or signal element including the circuit
Inventor: STAHL ROBERT
IPC: H05B44/00
Filed: 2011-05-11
Abstract: The present invention relates to a circuit for controlling at least one LED  and to a light- and/or signal element including said circuit, wherein the circuit facilitates an optimum utilization of any input voltage provided by an energy source and provides constant light intensity of the LEDs independent from an input voltage. For this purpose, the circuit contains a step-up converter arranged in the circuit in a way, that the step- up converter outputs a voltage adapted to a forward voltage of the at least one LED at a constant current independent from an input voltage provided by the energy source.
Patent CA-2740829-A1 (CA)
Inventor: LIN KUN-YU
IPC: H04L12/16
Filed: 2011-05-19
Abstract: Disclosed is a system and method of network data access management, a client terminal sends out a file request to a server, said server transmits said file request to a database and fetches a file corresponding to said file request from said database and transmits it back to said client terminal, said server transmits and stores file information of said file into a virtual database, such that when said client terminal edits said file, it will also modify said file information of said corresponding file in said virtual database simultaneously, and upon finishing editing said file, said virtual database transmits said edited file information to said database through said server.  Then, said database will modify said file in said database as based on said edited file information, thus decreasing number of access of said database by said client terminal, reducing bandwidth required significantly, and increasing efficacy of network data access.
Patent CA-2741945-A1 (CA)
Inventor: PODHAJSKY RONALD J
IPC: A61B10/00
Filed: 2011-06-02
Abstract: A method of controlling output of an electrosurgical power generating source includes the steps of receiving image data including tissue temperature information of a target tissue volume, calculating a specific absorption rate as a function of the tissue temperature information from the image data, and determining one or more operating parameters associated with the electrosurgical power generating source based on the calculated specific absorption rate.
Patent CA-2742131-A1 (CA)
Title: Space weather prediction system and method
Inventor: INTRILIGATOR DEVRIE S
IPC: G01W1/10
Filed: 2001-04-18
Abstract: System and method of forecasting space weather (at Earth or another location) based on identifying complex patterns in solar, interplanetary, or geophysical data. These data may include current or historical measurements and/or modeled data (predicted or simulated). Data patterns (both non-event and event-related) are identified (even when another event is occurring). Such patterns may vary with recent/cyclic variations in solar (e.g. solar max/min), interplanetary, or geophysical activity.  Embodiments are built around: templates, expert systems, neural networks, hybrid systems comprising combinations of these, and multimodal intelligent systems.  Forecasts are customized and/or updated as new data arise and as systems are dynamically modified (e.g.  via feedback between system parts). Numerical or other indexes are generated representing forecasts, associated confidence levels, etc.
Patent CA-2743609-A1 (CA)
Inventor: TING PAULINE C
IPC: C07D413/14
Filed: 2009-11-17
Abstract: The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase ("DGAT") inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below:  formula (I).
Patent CA-2743697-A1 (CA)
Inventor: ANVERSA PIERO
IPC: A61K35/12
Filed: 2008-11-26
Abstract: The invention describes the isolation and methods of use of a non-senescent pool of adult cardiac stem cells. Methods for repairing aged myocardium or damaged myocardium using the isolated non-senescent adult cardiac stem cells are also disclosed. In addition, the invention describes a method for preventing or treating heart failure.
Patent CA-2746746-A1 (CA)
Inventor: BUENO MELENDO ANA BELEN
IPC: A61K31/427
Filed: 2009-12-11
Abstract: A compound of formula (A); and pharmaceutical compositions for the treatment of diabetes.
Patent CA-2749229-A1 (CA)
Inventor: RANTA CRAIG ERIC
IPC: H04W88/02
Filed: 2008-10-30
Abstract: A degree of seal of an ear about a speaker port may be estimated by detecting touch contact between the ear and at least one touch sensor in fixed relation to the speaker port. The degree of seal is estimated based on the detected touch contact. Based upon the estimated degree of seal, the acoustic output of the speaker may be adjusted. The adjustment may compensate for perceived changes to the quality of the acoustic output resulting from the degree of seal. The at least one touch sensor may be a plurality of touch sensors spaced around the speaker port. Each sensor may have a truncated wedge shape, with a narrow end closest to the speaker port.
Patent CA-2750539-A1 (CA)
Title: N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops
Inventor: ECKELBARGER JOSEPH
IPC: C07D239/28
Filed: 2010-02-25
Abstract: N-Alkoxyamides of 4-aminopicolinnic and-4-pyrimidinecarboxylates of formula (I) are selective herbicides for corn, canola and sugar beet.
Patent CA-2753326-A1 (CA)
Inventor: PEDAIN KLAUS-ULRICH
IPC: B03D1/008
Filed: 2010-02-10
Abstract: The invention relates to a method for separating insoluble components from sylvinite, wherein the sylvinite is suspended in a saturated salt brine, a coagulating agent is added to the suspension, and a foaming agent is then added to the composition thus obtained, said foaming agent comprising and ether and/or ester, wherein a) the ethers of formula 1 correspond to R-O-R' (1), where R is a linear or branched alkyl or alkenyl groups having 2 to 30 carbon atoms and R' is a linear or branched alkyl or alkenyl groups having 1 to 30 carbon atoms; b) the esters are derived from monovalent or multivalent alcohols having 1 to 30 carbon atoms (alcohol radicals); or c) the ethers and/or esters are cyclic, wherein the ring size is 6 to 30 carbon atoms.
Patent CA-2753915-A1 (CA)
Inventor: ALT JESSIE LYNN
IPC: A01H5/10
Filed: 2011-03-17
Abstract: According to the invention, there is provided a novel soybean variety designated XB25X11. This invention thus relates to the seeds of soybean variety XB25X11, to the plants of soybean XB25X11 to plant parts of soybean variety XB25X11 and to methods for producing a soybean plant produced by crossing plants of the soybean variety XB25X1 1 with another soybean plant, using XB25X11 as either the male or the female parent.
Patent CA-2756473-A1 (CA)
Title: Polyolefin graft poly(meth)acrylate copolymer-based adhesion promoter for coating polyolefin surfaces
Inventor: KOHLSTRUK STEPHAN
IPC: C09J151/00
Filed: 2010-02-26
Abstract: The invention relates to a novel halogen-free and acid-free, readily soluble adhesion promoter for polyolefins, said promoter containing (meth)acrylate-grafted, amorphous polyolefins.
Patent CA-2756725-A1 (CA)
Inventor: SADEE WOLFGANG
IPC: C12Q1/68
Filed: 2010-03-26
Abstract: A method for predicting a subject's risk factors for CYP3A4-related disorders includes detecting the allelic status of a SNP in a nucleic acid sample of the subject.
Patent CA-2756914-A1 (CA)
Title: Turbofan mounting arrangement
Inventor: HEYERMAN JEFFREY BERNARD
IPC: F02C7/20
Filed: 2011-11-04
Abstract: A gas turbine engine has a rear mounting structure incorporating a mounting apparatus attached to a bypass duct wall with a link device of six rods for transferring core portion related inertia-induced loads, from an inner case of the core portion in a short circuit across an annular bypass air passage to the bypass duct wall.
Patent CA-2757357-A1 (CA)
Inventor: KIM TAE-HYEON
IPC: H04W36/08
Filed: 2010-04-30
Abstract: Disclosed is a method of controlling connection establishment in a server in charge of the control plane within a mobile communication network. The method of controlling connection establishment may include receiving a connection request message including a parameter indicating an identifier of a local gateway from a base station. The connection request message may include an access request message by the UE.  The method of controlling connection establishment may further include determining whether a bearer for the UE is set to a path through nodes within the mobile communication network or set to a path through nodes within another wired network accessible by the local gateway by considering at least one of QoS, subscriber information for the UE, operator policy if the connection request message is received. If it is set to a path through nodes within the another wired network, the method of controlling connection establishment may further include transmitting a connection response message including a parameter indicating whether the bearer has been set or should be set to a path through nodes within the another wired network and an address of the local gateway to the base station.
Patent CA-2758310-A1 (CA)
Title: Rice zinc finger protein transcription factor dst and use thereof for regulating drought and salt tolerance
Inventor: LIN HONGXUAN
IPC: A01H1/00
Filed: 2010-04-07
Abstract: Provided are zinc finger protein transcription factor DST having the amino acid sequence as shown in SEQ ID NO: 2, conservative variants and homologous polypeptides thereof. Also provided are DNA sequence encoding the transcription factor DST, vector or host cell comprising the DNA sequence, cis-acting element binding to the DST, inhibitor or non-conservative variant of the transcription factor DST or encoding sequence thereof, and use of the inhibitor or non-conservative variant for improving the drought and salt tolerance in plant.
Patent CA-2760852-A1 (CA)
Title: Vertical pouch machine
Inventor: FRIEVALT CURT
IPC: B65B9/06
Filed: 2005-04-21
Abstract: A vertical form fill and seal continuous pouch machine includes a forming tube having a cross section area of CA is disclosed. A film tube is continuously formed about the forming tube and fed downward. A horizontal sealing assembly includes at least one pair of opposing sealing bars that make horizontal seals on the film, thereby forming pouches. The horizontal seals are formed in a horizontal sealing zone, and the vertical distance from a lower end of the forming tube to the center of the horizontal sealing zone is a transition distance that is (in inches) preferably no more than 0.5 multiplied by the cross-section area (in sq inches).
Patent CA-2762338-A1 (CA)
Title: Therapy for subarachnoid hemorrhage and ischemia
Inventor: TYMIANSKI MICHAEL
IPC: A61B5/055
Filed: 2011-12-15
Abstract: The application provides data from a clinical trial of a PSD-95 inhibitor in subjects undergoing endovascular repair of an aneurysm in or otherwise affecting the CNS. The subjects were stratified by whether the aneurysm ruptured before performing the endovascular surgery. Rupture is associated with higher mortality or increased debilitation if a subject survives. The trial provided evidence of significant benefit in subjects with and without aneurysm rupture before endovascular was surgery performed. Surprisingly, the subjects benefitting most from treatment as judged both by pathology and neurocognitive outcome were those in which the aneurysm had ruptured causing a subarachnoid hemorrhage. These data constitute evidence that a PSD-95 inhibitor is beneficial not only in ischemic and hemorrhagic stroke but in forms of hemorrhage in or affecting the CNS, particularly, subarachnoid hemorrhage.